Overview

Ultrasound-guided Transmuscular Quadratus Lumborum Block for Elective Caesarean Section.

Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
0
Participant gender:
Female
Summary
ECS is a very common procedure. A 1-year retrospective survey revealed a vast opioid consumption among the new mothers of approximately (mean±SD) 35±25 mg of oral morphine in the first 24 postoperative hours despite a multimodal analgesic regimen. The adverse effects of morphine are well known and include postoperative nausea and vomiting (PONV), itching, fatigue, constipation, confusion, respiratory depression and delayed mobilization. These adverse effects are unsound for the new mothers as well as the breast-fed, newborn children. This study aims to evaluate the efficacy of bilateral Transmuscular Quadratus Lumborum (TQL) block in reducing postoperative morphine consumption and pain.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Zealand University Hospital
Treatments:
Acetaminophen
Ibuprofen
Morphine
Ropivacaine
Criteria
Inclusion Criteria:

- Pregnant women scheduled for elective Caesarean Section in spinal anaesthesia.

- Have received thorough information, orally and in written, and signed the "Informed
Consent" form on participation in the trial

Exclusion Criteria:

- Inability to cooperate

- Inability to speak and understand Danish

- Allergy to local anaesthetics or opioids

- Daily intake of opioids

- Local infection at the site of injection or systemic infection

- Difficulty visualisation of muscular and fascial structures in ultrasound
visualisation necessary to the block administration